

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62375174 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.62375174 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.28647731 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.26721264 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.26721264 |
| 6 | omega-hydroxylase P450 pathway (GO:0097267) | 7.06052641 |
| 7 | exogenous drug catabolic process (GO:0042738) | 7.01858107 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.90967225 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.34783481 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.34783481 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.34783481 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.23664392 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.21035773 |
| 14 | bile acid biosynthetic process (GO:0006699) | 6.03233516 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.96323699 |
| 16 | regulation of plasminogen activation (GO:0010755) | 5.93688643 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.73569290 |
| 18 | urea cycle (GO:0000050) | 5.65531088 |
| 19 | urea metabolic process (GO:0019627) | 5.65531088 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.61679557 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.57784748 |
| 22 | oxidative demethylation (GO:0070989) | 5.52648424 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.49255399 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.45762727 |
| 25 | negative regulation of protein activation cascade (GO:2000258) | 5.44168574 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.43988546 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.42848113 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.39917487 |
| 29 | protein carboxylation (GO:0018214) | 5.39917487 |
| 30 | cysteine metabolic process (GO:0006534) | 5.28951181 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 5.22583096 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.19401389 |
| 33 | bile acid metabolic process (GO:0008206) | 5.14738374 |
| 34 | regulation of complement activation (GO:0030449) | 5.08165815 |
| 35 | regulation of humoral immune response (GO:0002920) | 5.07576449 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 5.05759171 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 5.01039859 |
| 38 | intestinal cholesterol absorption (GO:0030299) | 5.00916112 |
| 39 | ethanol metabolic process (GO:0006067) | 4.94871488 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.93642257 |
| 41 | drug metabolic process (GO:0017144) | 4.92893742 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.82858138 |
| 43 | homocysteine metabolic process (GO:0050667) | 4.79787124 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.78762626 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.78220661 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.75012149 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.73690540 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.73690540 |
| 49 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72777043 |
| 50 | protein-lipid complex remodeling (GO:0034368) | 4.72777043 |
| 51 | macromolecular complex remodeling (GO:0034367) | 4.72777043 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.65658485 |
| 53 | lysine catabolic process (GO:0006554) | 4.61465657 |
| 54 | lysine metabolic process (GO:0006553) | 4.61465657 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 4.61322272 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.60325574 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.60325574 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.56679901 |
| 59 | negative regulation of cholesterol transport (GO:0032375) | 4.56679901 |
| 60 | amino-acid betaine metabolic process (GO:0006577) | 4.56413998 |
| 61 | negative regulation of complement activation (GO:0045916) | 4.51460942 |
| 62 | phospholipid efflux (GO:0033700) | 4.50463653 |
| 63 | coenzyme catabolic process (GO:0009109) | 4.49576750 |
| 64 | indolalkylamine metabolic process (GO:0006586) | 4.49034398 |
| 65 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.47120777 |
| 66 | imidazole-containing compound metabolic process (GO:0052803) | 4.43931228 |
| 67 | bile acid and bile salt transport (GO:0015721) | 4.41915885 |
| 68 | amine catabolic process (GO:0009310) | 4.41033246 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 4.41033246 |
| 70 | glycine metabolic process (GO:0006544) | 4.36307593 |
| 71 | cellular ketone body metabolic process (GO:0046950) | 4.35484180 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.32208186 |
| 73 | negative regulation of coagulation (GO:0050819) | 4.30799406 |
| 74 | glutamate metabolic process (GO:0006536) | 4.29595694 |
| 75 | positive regulation of blood coagulation (GO:0030194) | 4.29111722 |
| 76 | positive regulation of hemostasis (GO:1900048) | 4.29111722 |
| 77 | cellular amino acid catabolic process (GO:0009063) | 4.26492990 |
| 78 | cellular glucuronidation (GO:0052695) | 4.24179974 |
| 79 | negative regulation of wound healing (GO:0061045) | 4.22744293 |
| 80 | cholesterol efflux (GO:0033344) | 4.21107642 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.19706044 |
| 82 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.18328756 |
| 83 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.18328756 |
| 84 | serine family amino acid metabolic process (GO:0009069) | 4.13598899 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.08230433 |
| 86 | ethanol oxidation (GO:0006069) | 4.06317744 |
| 87 | fibrinolysis (GO:0042730) | 4.03633351 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.02642016 |
| 89 | phenylpropanoid metabolic process (GO:0009698) | 4.02083978 |
| 90 | low-density lipoprotein particle remodeling (GO:0034374) | 3.98919190 |
| 91 | protein-lipid complex subunit organization (GO:0071825) | 3.98553616 |
| 92 | plasma lipoprotein particle assembly (GO:0034377) | 3.98223808 |
| 93 | arginine metabolic process (GO:0006525) | 3.97475697 |
| 94 | serine family amino acid biosynthetic process (GO:0009070) | 3.95227757 |
| 95 | drug catabolic process (GO:0042737) | 3.94688822 |
| 96 | aldehyde catabolic process (GO:0046185) | 3.92792094 |
| 97 | positive regulation of coagulation (GO:0050820) | 3.92478237 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.88896646 |
| 99 | cofactor catabolic process (GO:0051187) | 3.86994980 |
| 100 | blood coagulation, intrinsic pathway (GO:0007597) | 3.86093833 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.84138183 |
| 102 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81163605 |
| 103 | complement activation (GO:0006956) | 3.79761784 |
| 104 | protein activation cascade (GO:0072376) | 3.77760590 |
| 105 | acute inflammatory response (GO:0002526) | 3.76847358 |
| 106 | ketone body metabolic process (GO:1902224) | 3.76748786 |
| 107 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.76292797 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.75923766 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.75923766 |
| 110 | positive regulation of lipid catabolic process (GO:0050996) | 3.74369045 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 3.73021177 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.72585738 |
| 113 | organic acid catabolic process (GO:0016054) | 3.72466213 |
| 114 | carboxylic acid catabolic process (GO:0046395) | 3.72466213 |
| 115 | regulation of cholesterol homeostasis (GO:2000188) | 3.71968848 |
| 116 | negative regulation of lipase activity (GO:0060192) | 3.71514830 |
| 117 | phospholipid homeostasis (GO:0055091) | 3.71163575 |
| 118 | protein-lipid complex assembly (GO:0065005) | 3.70926177 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.69634574 |
| 120 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.69634574 |
| 121 | cytolysis (GO:0019835) | 3.69366154 |
| 122 | opsonization (GO:0008228) | 3.67435470 |
| 123 | sterol homeostasis (GO:0055092) | 3.66345299 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 3.62706971 |
| 125 | NAD biosynthetic process (GO:0009435) | 3.60680313 |
| 126 | plasma lipoprotein particle organization (GO:0071827) | 3.60014893 |
| 127 | acute-phase response (GO:0006953) | 3.56405667 |
| 128 | regulation of acute inflammatory response (GO:0002673) | 3.55075978 |
| 129 | negative regulation of humoral immune response (GO:0002921) | 3.52716156 |
| 130 | lipoprotein metabolic process (GO:0042157) | 3.48808986 |
| 131 | S-adenosylmethionine metabolic process (GO:0046500) | 3.44212873 |
| 132 | peptidyl-glutamic acid modification (GO:0018200) | 3.43235122 |
| 133 | urate metabolic process (GO:0046415) | 3.35665690 |
| 134 | proline metabolic process (GO:0006560) | 3.34951570 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.38791520 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.17638313 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.06042811 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52529086 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.37921339 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.11250746 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.71988450 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.06819656 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.04342693 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06419994 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9609809 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94368315 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93053366 |
| 14 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61214722 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.58065247 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52621384 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45588654 |
| 18 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40434983 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32105362 |
| 20 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19976701 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19959839 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18675575 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17303025 |
| 24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12928973 |
| 25 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08353044 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06459462 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03006703 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00176604 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.95869573 |
| 30 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93445924 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91766759 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91278252 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.88213515 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.85850870 |
| 35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84617920 |
| 36 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84539278 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82769219 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81617676 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.80824897 |
| 40 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.79713065 |
| 41 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79688110 |
| 42 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79239173 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77873808 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74658989 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74543156 |
| 46 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74146085 |
| 47 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73974045 |
| 48 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73231716 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71329448 |
| 50 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71282128 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69282982 |
| 52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69136571 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.69010798 |
| 54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68864519 |
| 55 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.65962290 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.65688732 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.65688732 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.65266626 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.63994050 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63972730 |
| 61 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.63711303 |
| 62 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63370366 |
| 63 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.62632085 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62026514 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 0.60718832 |
| 66 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.60163846 |
| 67 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.59168503 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58905801 |
| 69 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58785647 |
| 70 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.58241856 |
| 71 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57922325 |
| 72 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.57887124 |
| 73 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.57687876 |
| 74 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.57010648 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56856780 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56288794 |
| 77 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.55126543 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.54458570 |
| 79 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.54333535 |
| 80 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.53169410 |
| 81 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.52873845 |
| 82 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.52823133 |
| 83 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52741491 |
| 84 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.52523120 |
| 85 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.51830548 |
| 86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.51306170 |
| 87 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51259550 |
| 88 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51208446 |
| 89 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.50770449 |
| 90 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50559079 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50339092 |
| 92 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.49814965 |
| 93 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49628904 |
| 94 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49535745 |
| 95 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.49517749 |
| 96 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49500864 |
| 97 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.48790171 |
| 98 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.48766645 |
| 99 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48570909 |
| 100 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48486774 |
| 101 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48466093 |
| 102 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.48063208 |
| 103 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.47678059 |
| 104 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46635687 |
| 105 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.46559553 |
| 106 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.46552629 |
| 107 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.46379221 |
| 108 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46344189 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.46186534 |
| 110 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45347916 |
| 111 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.44117986 |
| 112 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43336924 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.42998685 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.42232140 |
| 115 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42097153 |
| 116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41746955 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41143830 |
| 118 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.40916772 |
| 119 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40124652 |
| 120 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40103575 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39630247 |
| 122 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.39111395 |
| 123 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38859773 |
| 124 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38593228 |
| 125 | GATA2_19941826_ChIP-Seq_K562_Human | 0.38277357 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38209783 |
| 127 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37694138 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.37678759 |
| 129 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.37638635 |
| 130 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37446406 |
| 131 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.36595097 |
| 132 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35197816 |
| 133 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.34448419 |
| 134 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34405256 |
| 135 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34364403 |
| 136 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.34255255 |
| 137 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34021808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.34842459 |
| 2 | MP0005360_urolithiasis | 7.51591498 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.54354534 |
| 4 | MP0005365_abnormal_bile_salt | 6.20651957 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.15515773 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.17734519 |
| 7 | MP0003252_abnormal_bile_duct | 3.99379454 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.57550838 |
| 9 | MP0005083_abnormal_biliary_tract | 3.17169464 |
| 10 | MP0009840_abnormal_foam_cell | 3.16017161 |
| 11 | MP0003195_calcinosis | 2.91545281 |
| 12 | MP0005332_abnormal_amino_acid | 2.74738562 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.60468029 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.27005753 |
| 15 | MP0000609_abnormal_liver_physiology | 2.17111052 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.13161756 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.10823600 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.98410851 |
| 19 | MP0003868_abnormal_feces_composition | 1.91200835 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81580858 |
| 21 | MP0001764_abnormal_homeostasis | 1.64849832 |
| 22 | MP0009697_abnormal_copulation | 1.60450523 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53745579 |
| 24 | MP0001915_intracranial_hemorrhage | 1.51322706 |
| 25 | MP0005451_abnormal_body_composition | 1.43884979 |
| 26 | MP0003122_maternal_imprinting | 1.38936066 |
| 27 | MP0003011_delayed_dark_adaptation | 1.34823093 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.24226305 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.21740528 |
| 30 | MP0003186_abnormal_redox_activity | 1.20811333 |
| 31 | MP0000598_abnormal_liver_morphology | 1.17916482 |
| 32 | MP0005647_abnormal_sex_gland | 1.16984784 |
| 33 | MP0000566_synostosis | 1.13576751 |
| 34 | MP0003705_abnormal_hypodermis_morpholog | 1.10984381 |
| 35 | MP0009764_decreased_sensitivity_to | 1.07154851 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.05464579 |
| 37 | MP0000604_amyloidosis | 1.04715335 |
| 38 | MP0002254_reproductive_system_inflammat | 1.04167242 |
| 39 | MP0009763_increased_sensitivity_to | 1.02701995 |
| 40 | MP0010368_abnormal_lymphatic_system | 0.99838302 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 0.93179978 |
| 42 | MP0008469_abnormal_protein_level | 0.89435177 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 0.88556883 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.87012110 |
| 45 | MP0005670_abnormal_white_adipose | 0.86377776 |
| 46 | MP0003172_abnormal_lysosome_physiology | 0.82692563 |
| 47 | MP0005408_hypopigmentation | 0.82567230 |
| 48 | MP0002089_abnormal_postnatal_growth/wei | 0.82483020 |
| 49 | MP0003879_abnormal_hair_cell | 0.79711743 |
| 50 | MP0002876_abnormal_thyroid_physiology | 0.78319992 |
| 51 | MP0005376_homeostasis/metabolism_phenot | 0.78155330 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.78041060 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 0.77803479 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.77403228 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.76407513 |
| 56 | MP0002971_abnormal_brown_adipose | 0.74081558 |
| 57 | MP0002282_abnormal_trachea_morphology | 0.71709483 |
| 58 | MP0005334_abnormal_fat_pad | 0.69636617 |
| 59 | MP0004130_abnormal_muscle_cell | 0.69004595 |
| 60 | MP0005535_abnormal_body_temperature | 0.66870844 |
| 61 | MP0001661_extended_life_span | 0.66682038 |
| 62 | MP0003690_abnormal_glial_cell | 0.66412653 |
| 63 | MP0005266_abnormal_metabolism | 0.63152508 |
| 64 | MP0005187_abnormal_penis_morphology | 0.62606300 |
| 65 | MP0009053_abnormal_anal_canal | 0.61510943 |
| 66 | MP0003329_amyloid_beta_deposits | 0.59609666 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 0.59244011 |
| 68 | MP0000639_abnormal_adrenal_gland | 0.59243298 |
| 69 | MP0001756_abnormal_urination | 0.58397727 |
| 70 | MP0003123_paternal_imprinting | 0.55984790 |
| 71 | MP0006035_abnormal_mitochondrial_morpho | 0.55607065 |
| 72 | MP0005448_abnormal_energy_balance | 0.54372062 |
| 73 | MP0005464_abnormal_platelet_physiology | 0.54144690 |
| 74 | MP0002928_abnormal_bile_duct | 0.53038932 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.52301058 |
| 76 | MP0006054_spinal_hemorrhage | 0.51396589 |
| 77 | MP0003724_increased_susceptibility_to | 0.49032374 |
| 78 | MP0005395_other_phenotype | 0.48315945 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.47572360 |
| 80 | MP0002909_abnormal_adrenal_gland | 0.47442472 |
| 81 | MP0002822_catalepsy | 0.46783140 |
| 82 | MP0008874_decreased_physiological_sensi | 0.46473147 |
| 83 | MP0002136_abnormal_kidney_physiology | 0.45960743 |
| 84 | MP0003633_abnormal_nervous_system | 0.45556506 |
| 85 | MP0003436_decreased_susceptibility_to | 0.45004628 |
| 86 | MP0003718_maternal_effect | 0.44765852 |
| 87 | MP0008873_increased_physiological_sensi | 0.43630591 |
| 88 | MP0002249_abnormal_larynx_morphology | 0.42983408 |
| 89 | MP0000579_abnormal_nail_morphology | 0.41833716 |
| 90 | MP0005377_hearing/vestibular/ear_phenot | 0.41580851 |
| 91 | MP0003878_abnormal_ear_physiology | 0.41580851 |
| 92 | MP0003953_abnormal_hormone_level | 0.40605200 |
| 93 | MP0009384_cardiac_valve_regurgitation | 0.39885273 |
| 94 | MP0003075_altered_response_to | 0.39644860 |
| 95 | MP0005166_decreased_susceptibility_to | 0.39427088 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.39204230 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.38854286 |
| 98 | MP0005023_abnormal_wound_healing | 0.38739404 |
| 99 | MP0004381_abnormal_hair_follicle | 0.38736600 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.38279832 |
| 101 | MP0005248_abnormal_Harderian_gland | 0.37318722 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.37233612 |
| 103 | MP0004272_abnormal_basement_membrane | 0.36498040 |
| 104 | MP0008872_abnormal_physiological_respon | 0.34902047 |
| 105 | MP0009672_abnormal_birth_weight | 0.34892050 |
| 106 | MP0006292_abnormal_olfactory_placode | 0.33359328 |
| 107 | MP0003631_nervous_system_phenotype | 0.32647287 |
| 108 | MP0009115_abnormal_fat_cell | 0.32145788 |
| 109 | MP0000230_abnormal_systemic_arterial | 0.32090522 |
| 110 | MP0006082_CNS_inflammation | 0.31840131 |
| 111 | MP0000920_abnormal_myelination | 0.31839121 |
| 112 | MP0002168_other_aberrant_phenotype | 0.31612530 |
| 113 | MP0000249_abnormal_blood_vessel | 0.30572067 |
| 114 | MP0001853_heart_inflammation | 0.30524148 |
| 115 | MP0009785_altered_susceptibility_to | 0.30332861 |
| 116 | MP0001243_abnormal_dermal_layer | 0.30100472 |
| 117 | MP0002970_abnormal_white_adipose | 0.29839126 |
| 118 | MP0003632_abnormal_nervous_system | 0.29570610 |
| 119 | MP0001881_abnormal_mammary_gland | 0.29457673 |
| 120 | MP0002796_impaired_skin_barrier | 0.28989538 |
| 121 | MP0004883_abnormal_blood_vessel | 0.28179512 |
| 122 | MP0002092_abnormal_eye_morphology | 0.28142742 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.27448689 |
| 124 | MP0001324_abnormal_eye_pigmentation | 0.27292014 |
| 125 | MP0001845_abnormal_inflammatory_respons | 0.27214713 |
| 126 | MP0005257_abnormal_intraocular_pressure | 0.26914962 |
| 127 | MP0001293_anophthalmia | 0.26884974 |
| 128 | MP0002697_abnormal_eye_size | 0.25643819 |
| 129 | MP0002060_abnormal_skin_morphology | 0.24717611 |
| 130 | MP0002132_abnormal_respiratory_system | 0.23947539 |
| 131 | MP0005164_abnormal_response_to | 0.23642135 |
| 132 | MP0000427_abnormal_hair_cycle | 0.22371190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.42598676 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.41751797 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39414933 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.69250324 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.69109450 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.39158701 |
| 7 | Xanthomatosis (HP:0000991) | 6.31007117 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.55169582 |
| 9 | Complement deficiency (HP:0004431) | 5.50162086 |
| 10 | Joint hemorrhage (HP:0005261) | 4.85895372 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.77642135 |
| 12 | Epidermoid cyst (HP:0200040) | 4.62270677 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.58577137 |
| 14 | Hyperammonemia (HP:0001987) | 4.54628629 |
| 15 | Hyperglycinemia (HP:0002154) | 4.39488799 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.37265002 |
| 17 | Abnormality of methionine metabolism (HP:0010901) | 4.29176183 |
| 18 | Ketosis (HP:0001946) | 4.24690116 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.23784963 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.20454134 |
| 21 | Fat malabsorption (HP:0002630) | 4.16733651 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.12679398 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11456105 |
| 24 | Abnormality of complement system (HP:0005339) | 4.00992660 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.87157981 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.87157981 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.86707575 |
| 28 | Hyperglycinuria (HP:0003108) | 3.85749331 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.83914935 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83113716 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.81120450 |
| 32 | Hypercholesterolemia (HP:0003124) | 3.67915141 |
| 33 | Hyperbilirubinemia (HP:0002904) | 3.35463924 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31486388 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.27351568 |
| 36 | Spontaneous abortion (HP:0005268) | 3.25445403 |
| 37 | Steatorrhea (HP:0002570) | 3.13593309 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.09390567 |
| 39 | Myocardial infarction (HP:0001658) | 3.08576859 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06419786 |
| 41 | Purpura (HP:0000979) | 3.05445861 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.02961288 |
| 43 | Ketoacidosis (HP:0001993) | 3.01027395 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.99123884 |
| 45 | Hypochromic microcytic anemia (HP:0004840) | 2.92479273 |
| 46 | Skin nodule (HP:0200036) | 2.85559012 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.79374828 |
| 48 | Osteomalacia (HP:0002749) | 2.71416465 |
| 49 | Metabolic acidosis (HP:0001942) | 2.70709258 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.68072821 |
| 51 | Arthropathy (HP:0003040) | 2.67848787 |
| 52 | Vascular calcification (HP:0004934) | 2.63188239 |
| 53 | Acanthocytosis (HP:0001927) | 2.58031227 |
| 54 | Lethargy (HP:0001254) | 2.55334924 |
| 55 | Mitral stenosis (HP:0001718) | 2.54180979 |
| 56 | Hypoglycemic seizures (HP:0002173) | 2.53308442 |
| 57 | Abnormal gallbladder morphology (HP:0012437) | 2.49633308 |
| 58 | Glomerulonephritis (HP:0000099) | 2.48731212 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48688724 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.48688724 |
| 61 | Gout (HP:0001997) | 2.48454738 |
| 62 | Spastic diplegia (HP:0001264) | 2.44409905 |
| 63 | Cholelithiasis (HP:0001081) | 2.42886732 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40220279 |
| 65 | Cerebral edema (HP:0002181) | 2.37772963 |
| 66 | Neonatal onset (HP:0003623) | 2.34221351 |
| 67 | Irritability (HP:0000737) | 2.34074117 |
| 68 | Cardiovascular calcification (HP:0011915) | 2.33190458 |
| 69 | Amyloidosis (HP:0011034) | 2.32846551 |
| 70 | Gingival bleeding (HP:0000225) | 2.32544860 |
| 71 | Pulmonary embolism (HP:0002204) | 2.30646012 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.30040409 |
| 73 | Cholecystitis (HP:0001082) | 2.30040409 |
| 74 | Malnutrition (HP:0004395) | 2.24138537 |
| 75 | Esophageal varix (HP:0002040) | 2.18435256 |
| 76 | Menorrhagia (HP:0000132) | 2.17331289 |
| 77 | Late onset (HP:0003584) | 2.15468008 |
| 78 | Fair hair (HP:0002286) | 2.15111868 |
| 79 | Sensorimotor neuropathy (HP:0007141) | 2.15098456 |
| 80 | Thrombophlebitis (HP:0004418) | 2.14832023 |
| 81 | Brushfield spots (HP:0001088) | 2.14169567 |
| 82 | Enlarged kidneys (HP:0000105) | 2.12240323 |
| 83 | Pancreatitis (HP:0001733) | 2.09474231 |
| 84 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05743168 |
| 85 | Hemorrhage of the eye (HP:0011885) | 2.05716019 |
| 86 | Poikilocytosis (HP:0004447) | 2.04228214 |
| 87 | Opisthotonus (HP:0002179) | 2.02654373 |
| 88 | Vomiting (HP:0002013) | 2.02267523 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 2.01846389 |
| 90 | Abnormality of the gallbladder (HP:0005264) | 2.01207044 |
| 91 | Neonatal hypoglycemia (HP:0001998) | 2.00516645 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 1.99065531 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94811693 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.94583735 |
| 95 | Rickets (HP:0002748) | 1.94208507 |
| 96 | Hypophosphatemic rickets (HP:0004912) | 1.92385891 |
| 97 | Abnormal tarsal ossification (HP:0008369) | 1.91111860 |
| 98 | Joint swelling (HP:0001386) | 1.88563506 |
| 99 | Epistaxis (HP:0000421) | 1.85655787 |
| 100 | Potter facies (HP:0002009) | 1.83515337 |
| 101 | Facial shape deformation (HP:0011334) | 1.83515337 |
| 102 | Hyperphosphaturia (HP:0003109) | 1.83080142 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 1.82616725 |
| 104 | Renal cortical cysts (HP:0000803) | 1.82304319 |
| 105 | Elevated hepatic transaminases (HP:0002910) | 1.81762375 |
| 106 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80671987 |
| 107 | Hydroxyprolinuria (HP:0003080) | 1.80493951 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.80493951 |
| 109 | Hyperglycemia (HP:0003074) | 1.80311494 |
| 110 | Abnormality of urine glucose concentration (HP:0011016) | 1.79407003 |
| 111 | Glycosuria (HP:0003076) | 1.79407003 |
| 112 | Alkalosis (HP:0001948) | 1.78986452 |
| 113 | Status epilepticus (HP:0002133) | 1.78749820 |
| 114 | Nephritis (HP:0000123) | 1.76652765 |
| 115 | Increased serum pyruvate (HP:0003542) | 1.76478343 |
| 116 | Abnormality of carpal bone ossification (HP:0006257) | 1.75425015 |
| 117 | Abnormality of vitamin metabolism (HP:0100508) | 1.71860845 |
| 118 | Increased serum ferritin (HP:0003281) | 1.70829925 |
| 119 | Gangrene (HP:0100758) | 1.69988634 |
| 120 | Neoplasm of the liver (HP:0002896) | 1.69395086 |
| 121 | Abnormal delivery (HP:0001787) | 1.63353199 |
| 122 | Bifid scrotum (HP:0000048) | 1.62602840 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.59958380 |
| 124 | Elevated alkaline phosphatase (HP:0003155) | 1.54110521 |
| 125 | Hypothermia (HP:0002045) | 1.52063824 |
| 126 | Back pain (HP:0003418) | 1.50797671 |
| 127 | Abnormal urine phosphate concentration (HP:0012599) | 1.50474037 |
| 128 | Abnormality of glycolysis (HP:0004366) | 1.50431752 |
| 129 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.47142813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.80900663 |
| 2 | FGFR4 | 4.67414081 |
| 3 | SIK1 | 4.58082924 |
| 4 | ERN1 | 4.36295036 |
| 5 | TAOK3 | 3.33911939 |
| 6 | ERBB4 | 3.26952062 |
| 7 | WNK4 | 3.20435429 |
| 8 | INSRR | 3.16805708 |
| 9 | CDK12 | 2.33320610 |
| 10 | MAP2K4 | 2.33057263 |
| 11 | PKN2 | 2.11185186 |
| 12 | MST1R | 2.09382776 |
| 13 | MAPK11 | 1.98688120 |
| 14 | FLT3 | 1.86351199 |
| 15 | DAPK2 | 1.77163755 |
| 16 | PIK3CG | 1.76879443 |
| 17 | TYRO3 | 1.75956699 |
| 18 | TYK2 | 1.73361794 |
| 19 | SMG1 | 1.72384602 |
| 20 | LATS1 | 1.66722233 |
| 21 | TRIB3 | 1.62737894 |
| 22 | NTRK3 | 1.59602903 |
| 23 | FGFR1 | 1.54581525 |
| 24 | PTK6 | 1.50099348 |
| 25 | ABL2 | 1.42021216 |
| 26 | PDGFRA | 1.41841988 |
| 27 | FGFR2 | 1.41574216 |
| 28 | AKT3 | 1.38922654 |
| 29 | NEK9 | 1.37358043 |
| 30 | FRK | 1.33367668 |
| 31 | JAK2 | 1.29801207 |
| 32 | KDR | 1.29437894 |
| 33 | BRSK2 | 1.25523978 |
| 34 | MAP3K7 | 1.25032967 |
| 35 | CDC42BPA | 1.22071916 |
| 36 | TAF1 | 1.21674456 |
| 37 | WNK1 | 1.21567452 |
| 38 | EIF2AK1 | 1.19547841 |
| 39 | PRKAA2 | 1.16284451 |
| 40 | ERBB2 | 1.15272788 |
| 41 | MAP3K14 | 1.10455031 |
| 42 | PINK1 | 1.09992077 |
| 43 | TBK1 | 1.08640104 |
| 44 | JAK1 | 1.08562435 |
| 45 | MAPK15 | 1.02646676 |
| 46 | CAMKK2 | 1.00206015 |
| 47 | GRK6 | 0.99711807 |
| 48 | MAP3K2 | 0.99179786 |
| 49 | MAPK4 | 0.98565921 |
| 50 | MAP2K3 | 0.98300377 |
| 51 | PRKCZ | 0.91860739 |
| 52 | MAP3K10 | 0.91501537 |
| 53 | STK38L | 0.87052829 |
| 54 | EPHB1 | 0.87041060 |
| 55 | DDR2 | 0.84246864 |
| 56 | EPHA3 | 0.83889310 |
| 57 | SIK2 | 0.82512677 |
| 58 | CSNK1E | 0.82468860 |
| 59 | MAPK12 | 0.80870326 |
| 60 | MET | 0.80391344 |
| 61 | CDK6 | 0.79120107 |
| 62 | EEF2K | 0.78705228 |
| 63 | TIE1 | 0.76776179 |
| 64 | MAP3K3 | 0.76236357 |
| 65 | PRKACG | 0.75440539 |
| 66 | CAMK2G | 0.74521720 |
| 67 | CAMK1D | 0.73954045 |
| 68 | IRAK3 | 0.72387257 |
| 69 | CSK | 0.70584858 |
| 70 | DYRK1B | 0.70067318 |
| 71 | SGK3 | 0.68464128 |
| 72 | PRKG1 | 0.67631330 |
| 73 | CDK7 | 0.67593761 |
| 74 | PRKAA1 | 0.67269642 |
| 75 | CSNK1D | 0.67073560 |
| 76 | GSK3A | 0.65608872 |
| 77 | MAP2K6 | 0.65128264 |
| 78 | FER | 0.65121220 |
| 79 | SGK1 | 0.63848741 |
| 80 | MAP3K11 | 0.63558954 |
| 81 | MAPKAPK3 | 0.63346297 |
| 82 | RIPK1 | 0.62899720 |
| 83 | FGFR3 | 0.60323673 |
| 84 | MAPK7 | 0.59673639 |
| 85 | MAPKAPK5 | 0.59423979 |
| 86 | IKBKE | 0.59140311 |
| 87 | CSF1R | 0.56389913 |
| 88 | PRKACA | 0.55589364 |
| 89 | EPHA4 | 0.54637428 |
| 90 | SGK2 | 0.54450658 |
| 91 | BRSK1 | 0.54077822 |
| 92 | PKN1 | 0.53957276 |
| 93 | VRK2 | 0.53116461 |
| 94 | NLK | 0.53011422 |
| 95 | TGFBR2 | 0.52916253 |
| 96 | PTK2 | 0.52630696 |
| 97 | RPS6KA3 | 0.50780615 |
| 98 | PRKCQ | 0.50602705 |
| 99 | PDPK1 | 0.49779133 |
| 100 | MAP3K13 | 0.49065334 |
| 101 | CSNK1G1 | 0.48678230 |
| 102 | GRK1 | 0.48104550 |
| 103 | FGR | 0.47747525 |
| 104 | RPS6KB1 | 0.47537476 |
| 105 | DAPK1 | 0.46239462 |
| 106 | IGF1R | 0.45005635 |
| 107 | CSNK2A2 | 0.42550451 |
| 108 | EPHA2 | 0.41426617 |
| 109 | SRC | 0.41199382 |
| 110 | MAP3K5 | 0.40280763 |
| 111 | RET | 0.40096005 |
| 112 | TAOK2 | 0.39769496 |
| 113 | PRKCG | 0.39409509 |
| 114 | CDK4 | 0.38702853 |
| 115 | STK39 | 0.38066066 |
| 116 | MAP2K1 | 0.37222802 |
| 117 | MTOR | 0.36628881 |
| 118 | MAP3K12 | 0.36207349 |
| 119 | SGK223 | 0.36036053 |
| 120 | SGK494 | 0.36036053 |
| 121 | EGFR | 0.34384603 |
| 122 | ICK | 0.34067979 |
| 123 | CAMK4 | 0.33638469 |
| 124 | PIK3CA | 0.33586375 |
| 125 | PRKCB | 0.32826990 |
| 126 | MAP3K6 | 0.32652947 |
| 127 | PRKG2 | 0.31980334 |
| 128 | CSNK2A1 | 0.31320638 |
| 129 | IRAK1 | 0.30857636 |
| 130 | PDK1 | 0.30394109 |
| 131 | MATK | 0.27876385 |
| 132 | CSNK1G2 | 0.27662905 |
| 133 | CAMK1G | 0.27165532 |
| 134 | PRKCA | 0.26540164 |
| 135 | IRAK2 | 0.26518100 |
| 136 | MAP3K1 | 0.25865575 |
| 137 | PBK | 0.25469257 |
| 138 | CHUK | 0.24534422 |
| 139 | CSNK1G3 | 0.22936390 |
| 140 | PAK3 | 0.22913879 |
| 141 | LATS2 | 0.22556853 |
| 142 | ABL1 | 0.22460299 |
| 143 | MAPK3 | 0.18976907 |
| 144 | PRKACB | 0.18315806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.59553004 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.61499419 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38416276 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34145290 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06294934 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83873908 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71667618 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.70972231 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59950130 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53118383 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47657077 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34794372 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.25228554 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14260775 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13981804 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.09992015 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.95682277 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.93074326 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.92338870 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91357887 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89064035 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.87872303 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82130059 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78314733 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77792595 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73759592 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72840170 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70807705 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69700750 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.68071874 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62286214 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55695153 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54928645 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.51630196 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49443684 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46579522 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44644582 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33866162 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30194974 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29407292 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29047998 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.28120676 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.24635281 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.20553129 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.19957482 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17663203 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14586507 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09418676 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06690580 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06574228 |
| 51 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97821466 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97146791 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.96230733 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95184483 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.90186978 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88192625 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85961127 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.85908049 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82410410 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76150618 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68990340 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66253730 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63661292 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56381494 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54073444 |
| 66 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52682884 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45251316 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45179849 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44836373 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.44722055 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.37115242 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25055685 |
| 73 | Insulin resistance_Homo sapiens_hsa04931 | 0.24616198 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24464435 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23312398 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21881404 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18762860 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16219076 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15748277 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.14595800 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12585851 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.05083165 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02595981 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2357141 |
| 85 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2348944 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2332183 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2225674 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2196821 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2086133 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1982182 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1947951 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1946407 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1920510 |
| 94 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1800823 |
| 95 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1720119 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1645203 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1629133 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1514956 |
| 99 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1513336 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1493323 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1353541 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1350906 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1341212 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0954951 |
| 105 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0870680 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0836479 |
| 107 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0744549 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0629265 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0609240 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0581962 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0207632 |

